BARTOLUCCI, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 306
EU - Europa 203
AS - Asia 120
Continente sconosciuto - Info sul continente non disponibili 1
Totale 630
Nazione #
US - Stati Uniti d'America 299
IE - Irlanda 112
CN - Cina 95
IT - Italia 56
DE - Germania 10
IR - Iran 8
CA - Canada 7
FI - Finlandia 7
FR - Francia 6
HK - Hong Kong 5
MY - Malesia 5
SE - Svezia 5
BE - Belgio 4
SG - Singapore 4
EU - Europa 1
GB - Regno Unito 1
GR - Grecia 1
IN - India 1
NL - Olanda 1
TR - Turchia 1
TW - Taiwan 1
Totale 630
Città #
Dublin 112
Chandler 106
Shanghai 22
Ashburn 16
Lawrence 15
Medford 15
Princeton 15
Beijing 14
Dearborn 12
Pavia 11
Ann Arbor 8
Jiaxing 8
Nanjing 8
Shenyang 8
Helsinki 7
Nanchang 7
Changsha 6
Dezful 6
Wilmington 6
Toronto 5
Brussels 4
Cagliari 4
Hangzhou 4
Hebei 4
Milan 4
New York 4
Fairfield 3
Jacksonville 3
Seattle 3
Stezzano 3
Tianjin 3
Castano Primo 2
Hefei 2
Kowloon 2
Novara 2
Romano di Lombardia 2
Shijiazhuang 2
Aosta 1
Atlanta 1
Bareggio 1
Falkenstein 1
Fuzhou 1
Heemskerk 1
Hong Kong 1
Kashan 1
Kish 1
Kunming 1
Los Angeles 1
Modena 1
Nagold 1
Navi Mumbai 1
Ningbo 1
Norwalk 1
Ottawa 1
Piscataway 1
Rockville 1
Sacramento 1
San Francisco 1
Shaoxing 1
Singapore 1
Taipei 1
Vaiano Cremasco 1
Washington 1
Winnipeg 1
Zhengzhou 1
Totale 486
Nome #
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions 61
A PBPK model for the study of Azathioprine pharmacokinetics in rats and prediction in humans 57
Whole-body PBPK model for a translational study of Azathioprine pharmacokinetics 56
Predicting Aqueous and Intrinsic Solubility of Pharmaceutical Molecules with Neural Networks 52
Development of a PBPK model for the study of Azathioprine pharmacokinetics in rats and translation to humans 47
Artificial intelligence and machine learning: just a hype or a new opportunity for pharmacometrics? 44
A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial Hypertension 41
Optimal design in pediatric clinical trials: theory and application to the macitentan case study 34
A genetic algorithm for covariate selection 33
Modeling approaches for reducing safety-related attrition in drug discovery and development: a review on myelotoxicity, immunotoxicity, cardiovascular toxicity, and liver toxicity 33
Optimal design of paediatric clinical trials: the Macitentan case study 32
Optimization of the sampling strategy for pediatric clinical trials: the importance of prior information 31
Development of a genetic algorithm for covariate analysis in population pharmacokinetic models 31
PKPD modelling of MEN1611 anti-tumor effect in xenograft models to predict efficacy threshold concentrations in HER2-positive advanced or metastatic breast cancer patient population 30
Application of Artificial Neural Networks to Predict the Intrinsic Solubility of Drug-Like Molecules 29
Facing the limits of the genetic algorithms for covariate selection 21
How Modelling and Simulations combined with Artificial Intelligence can improve Precision Dosing 18
A clinical trial simulator to predict the effect of an adaptive dosing regimen of an investigated compound on platelets, white blood cells and haematocrit in patients with Polycythemia Vera 6
Go beyond the limits of genetic algorithm in daily covariate selection practice 2
Totale 658
Categoria #
all - tutte 2.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 0 3
2019/202097 18 43 1 12 2 3 5 3 1 6 3 0
2020/202114 0 0 0 0 1 1 1 5 1 1 0 4
2021/202289 2 1 5 1 2 3 0 14 6 4 15 36
2022/2023299 28 29 2 15 26 23 2 24 125 0 8 17
2023/2024144 13 43 4 4 14 20 30 9 3 3 1 0
Totale 658